BioSpace News Archive

For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation’s annual Corporate Equality Index.

Sol-Gel Technologies Ltd. announced the presentation of results from the Company’s Phase 3 trials for its candidates Epsolay® for the treatment of moderate-to-severe papulopustular rosacea and Twyneo® for the treatment of moderate-to-severe acne vulgaris.

Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced that it has commenced an underwritten public offering of $325,000,000 in shares of its common stock.

Avantor, Inc. announced that its Board of Directors has declared a quarterly cash dividend to holders of its 6.250% Series A Mandatory Convertible Preferred Stock of $0.78 per share at a rate per share of 1.560%, payable on February 15, 2020 to holders of record on February 1, 2020.

Adaptimmune Therapeutics plc, a leader in T-cell therapy to treat cancer, announced that it intends to offer and sell American Depositary Shares in an underwritten public offering.

Eisai announced the presentation of three abstracts at the 2020 Gastrointestinal Cancers Symposium in San Francisco from January 23-25.

Cognate BioServices, a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapy products announced that it has completed the acquisition of Cobra Biologics, a leading CDMO specialized in providing development and manufacturing services for plasmid DNA and viral vector.

The Center for Neurological and Neurodevelopmental Health announced that it began mailing letters to patients potentially impacted by a recent incident.

At Three-Months, 80% of Patients Treated with DTM SCS Reported Back Pain Relief of at Least 50%; 63% Reported Profound Back Pain Relief of 80% or Greater

DisposeRx, Inc., manufacturer of the market leading at-home medication disposal solution, has in place a network of more than 1,000 pharmacies in New Jersey ready to meet the requirements of new legislation signed into law.